Report overview
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.?
This report contains market size and forecasts of Peptide Receptor Radionuclide Therapy (PRRT) in Global, including the following market information:
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peptide Receptor Radionuclide Therapy (PRRT) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gastroenteropancreatic Neuroendocrine Tumor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Receptor Radionuclide Therapy (PRRT) include Novartis, ITM Solucin, National Institutes of Health and Australasian Gastro-Intestinal Trials Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptide Receptor Radionuclide Therapy (PRRT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment Percentages, by Type, 2021 (%)
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Peptide Receptor Radionuclide Therapy (PRRT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Receptor Radionuclide Therapy (PRRT) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peptide Receptor Radionuclide Therapy (PRRT) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
ITM Solucin
National Institutes of Health
Australasian Gastro-Intestinal Trials Group
